Evaluation of new biomarkers in stage III and IV endometriosis
article
OA: diamond
CC0
⤵ 9 in-corpus citations
AI-generated summary
This study found that combining Ca-125 and Annexin A5 measurements improved endometriosis diagnosis sensitivity and specificity compared to Ca-125 alone.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To investigate the efficacy of new endometriosis biomarkers in diagnosis and treatment.
METHODS: Thirty women with Stage III-IV endometriosis who were given an indication for surgery and 49 control patients were compared. Preoperative and postoperative serum levels of Annexin A5 (ANXA5), soluble intercellular adhesion molecule-1 (sICAM-1), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), soluble vascular cell adhesion molecule-1 (sVCAM-1), vascular endothelial growth factors (VEGF) and Ca-125 measurements were compared.
RESULTS: AUCs of ANXA5, sICAM-1, IL-6, TNF-α, VCAM-1, VEGF biomarkers were not found to be significant in diagnosing endometriosis when evaluated alone (p > 0.05). Only the AUC of the Ca-125 biomarker values were found to be significant with 73% sensitivity and 98% specificity (p < 0.001). However, when Ca-125 and ANXA5 were evaluated together, it was concluded that the diagnosis of endometriosis could be made with 73% sensitivity and 100% specificity.
CONCLUSION: When Ca-125 and ANXA5 are evaluated together, it seems to be more valuable than Ca-125 alone in diagnosing endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (26)
- An overview on the relationship between endometriosis and infertility: the impact on sexuality and psychological well-being via openalex
- Biomarkers for the Noninvasive Diagnosis of Endometriosis: State of the Art and Future Perspectives via openalex
- Combination of the non-invasive tests for the diagnosis of endometriosis via openalex
- Diagnostic accuracy of cancer antigen 125 for endometriosis: a systematic review and meta‐analysis via openalex
- Differential expression of Lumican, Mimecan, Annexin A5 and Serotransferrin in ectopic and matched eutopic endometrium in ovarian endometriosis: a case-control study via openalex
- Endometriosis classification, staging and reporting systems: a review on the road to a universally accepted endometriosis classification, via openalex
- Evaluation of a panel of 28 biomarkers for the non-invasive diagnosis of endometriosis via openalex
- Evaluation of selected angiogenic and inflammatory markers in endometriosis before and after danazol treatment via openalex
- New biomarkers in endometriosis via openalex
- Noninvasive diagnosis of endometriosis: Review of current peripheral blood and endometrial biomarkers via openalex
- Novel diagnostic options for endometriosis – Based on the glycome and microbiome via openalex
- Pathophysiology, diagnosis, and management of endometriosis via openalex
- Soluble ICAM-1 levels in the serum of endometriotic patients appear to be independent of medical treatment via openalex
- Soluble VCAM-1/soluble ICAM-1 ratio is a promising biomarker for diagnosing endometriosis via openalex
- Technical Verification and Assessment of Independent Validation of Biomarker Models for Endometriosis via openalex
- The Inflammatory Role of Pro-Resolving Mediators in Endometriosis: An Integrative Review via openalex
- The Potential of Non-Invasive Biomarkers for Early Diagnosis of Asymptomatic Patients with Endometriosis via openalex
- The value of serological markers in the diagnosis and prognosis of endometriosis: a prospective case–control study via openalex
- Uterine Stem Cells and Benign Gynecological Disorders: Role in Pathobiology and Therapeutic Implications via openalex
- W2137773942 via openalex
- W3208334539 via openalex
- W4234160457 via openalex
- W2107597801 via openalex
- W1992451410 via openalex
- W2094889223 via openalex
- W2171863626 via openalex
Cited by (11)
- Serum Interleukin-6 Levels in Endometriosis and Endometriosis-Associated Ovarian Cancer: A Systematic Review and Meta-Analysis Demonstrating a Biological Gradient 2026
- Neutrophil-to-lymphocyte ratio and endometriosis: systematic review and meta-analysis 2026
- Creation of a rat model of ovarian endometriosis: a novel and easy approach to simulating chocolate cysts 2025
- The Molecular and Cellular Mechanisms of Endometriosis: From Basic Pathophysiology to Clinical Implications 2025
- <span data-contrast="auto">Evaluating the Prognostic Potential of CA-125 and miRNA Levels in Endometriosis: A Narrative Review <span data-ccp-props="{"> 2024
- Exploring the role of Chinese herbal medicine in the long-term management of postoperative ovarian endometriotic cysts: a systematic review and meta-analysis 2024
- Clinical indicators and reproductive tract microbiota abnormalities indicate the occurrence of endometriosis 2024
- Concurrent detection of the mitochondrial DNA copy number and the +35G/C polymorphism in the mitochondrial transcription factor A gene in endometriosis 2024
- Immune сheckpoints in the context of external genital endometriosis 2024
- Progesterone resistance in endometriosis: A pathophysiological perspective and potential treatment alternatives 2024
- Identification and exploration of potential N6-methylation related mRNAs in endometriosis 2024
Source provenance
- europepmc
- last seen: 2026-10-02T06:17:20.788884+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-02T06:16:17.985167+00:00
License: CC0
· commercial use OK